Missing/wrong data?
Log in to edit
S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma.
scientific article published on 28 May 2013
Author/s
author: Pascal Hammel, Jean-Baptiste Bachet, Jérôme Cros, Alain Sauvanet, Thierry André
Work details
Publication date
May 28, 2013
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.